1. Arrhythmogenic right ventricular cardiomyopathy.
- Author
-
Pike R
- Subjects
- Adult, Anti-Arrhythmia Agents therapeutic use, Arrhythmogenic Right Ventricular Dysplasia epidemiology, Arrhythmogenic Right Ventricular Dysplasia etiology, Catheter Ablation, Death, Sudden, Cardiac etiology, Defibrillators, Implantable, Genetic Predisposition to Disease genetics, Humans, Incidence, Mass Screening, Practice Guidelines as Topic, Risk Factors, Young Adult, Arrhythmogenic Right Ventricular Dysplasia diagnosis, Arrhythmogenic Right Ventricular Dysplasia therapy
- Abstract
Arrhythmogenic right ventricular cardiomyopathy is a cardiac disorder manifested by the replacement of the ventricular myocardium by fibro fatty tissue and has been known to cause sudden cardiac death in young adults. In 30% to 50% of cases, the disease has familial links, which can have implications for the patients and families involved. Achieving a diagnosis can be taxing on all involved, and for the patient, it can mean having to go through a battery of tests. Once diagnosis has been confirmed, treatment for the disease includes implantation of an implantable defibrillator and/or pharmacotherapy to control the ventricular tachyarrhythmias.
- Published
- 2009